Miyagawa M, Shirotori T, Tsuchitani M, Yoshikawa K
Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., Ibaraki, Japan.
Exp Toxicol Pathol. 1999 Nov;51(6):555-8. doi: 10.1016/S0940-2993(99)80142-0.
1,4-Dioxane is a nongenotoxic hepatocarcinogen but in our previous replicative DNA synthesis (RDS) studies with the [3H]thymidine (TdR)-technique, it failed to increase hepatocyte RDS values when given by gavage to male F344 rats as a single 2000 mg/kg body weight dose. However, in a current series of trials with TdR, it showed equivocal responses 24 or 48 hr following treatment with 2000 mg/kg in time-course experiments, and positive responses 24 hr following 1000, 1500 and 2000 mg/kg in dose-response experiments. An increased RDS incidence was also observed at the dose of 2000 mg/kg with data for 5-bromo-2'-deoxyuridine (BrdU)-incorporation. These present findings thus support the hypothesis that a capacity to induce cell proliferation may play a key role in 1,4-dioxane hepatocarcinogenesis.
1,4-二氧六环是一种非基因毒性的肝癌致癌物,但在我们之前使用[3H]胸腺嘧啶核苷(TdR)技术进行的复制性DNA合成(RDS)研究中,当以2000毫克/千克体重的单一剂量经口灌胃给予雄性F344大鼠时,它未能提高肝细胞RDS值。然而,在当前一系列使用TdR的试验中,在时间进程实验中,给予2000毫克/千克处理后24或48小时,它显示出不明确的反应;在剂量反应实验中,给予1000、1500和2000毫克/千克后24小时,它显示出阳性反应。在2000毫克/千克剂量下,通过5-溴-2'-脱氧尿苷(BrdU)掺入数据也观察到RDS发生率增加。因此,这些目前的发现支持了这样一种假设,即诱导细胞增殖的能力可能在1,4-二氧六环肝癌发生中起关键作用。